Expression of macrophage markers in cryoglobulinemic glomerulonephritis a - possible role of CXCL9

被引:5
|
作者
Kowalewska, J. [1 ]
Okon, K. [2 ]
Szynaka, B. [3 ]
Naumnik, B. [4 ,5 ]
机构
[1] Med Univ Bialystok, Dept Med Pathomorphol, PL-15269 Bialystok, Poland
[2] Jagiellonian Univ, Coll Med, Dept Pathomorphol, Krakow, Poland
[3] Med Univ Bialystok, Dept Histol, PL-15269 Bialystok, Poland
[4] Med Univ Bialystok, Dept Nephrol, PL-15269 Bialystok, Poland
[5] Med Univ Bialystok, Transplantat Dialysis Unit, PL-15269 Bialystok, Poland
来源
ADVANCES IN MEDICAL SCIENCES | 2013年 / 58卷 / 02期
关键词
Cryoglobulinemia; cryoglobulinemic glomerulonephritis; macrophages; CXCL9; HEPATITIS-C VIRUS; LYMPHOPOIETIN TRANSGENIC MICE; RENAL-ALLOGRAFT REJECTION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; CHEMOKINE RECEPTORS; INFECTION; KIDNEY; DISEASE; TRANSPLANTATION; MECHANISMS;
D O I
10.2478/ams-2013-0030
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose: Cryoglobulinemic glomerulonephritis (CGGN) is a type of membranoproliferative glomerulonephritis (MPGN) that develops in patients with systemic cryoglobulinemia. To date the exact pathogenesis of CGGN remains unclear. It has been suggested that macrophages may be significant contributors to the glomerular injury in this disease. In our study we attempt to characterize the macrophages in human CGGN using classical activation and regulatory macrophage markers. Material and Method: We searched our database for renal biopsy cases of CGGN. Macrophages were detected using a monoclonal anti-CD68 antibody. Two groups of macrophage markers were used: classical activation markers, including iNOS, CXCL9 and CCL20, and regulatory markers: SPHK1 and LIGHT. The stains were performed using immunohistochemical method. Results: Five patients with CGGN were identified. Four patients had systemic cryoglobulinemia and two had a serological evidence of hepatitis C virus infection. In all cases the glomeruli contained numerous macrophages. Staining for activatory macrophage markers revealed a strong nuclear staining for CXCL9 in numerous cells, including those corresponding to the macrophage location. Staining for the other activatory markers, as well as staining for regulatory markers, was not significant. Conclusion: In this study of human CGGN we showed a striking expression of cytokine CXCL9, a classical macrophage activation marker, by the macrophages and possibly other cell types within the glomeruli. This observation points to the possible role of classically activated macrophages in the pathogenesis of MPGN. If this observation is confirmed on a larger group of patients, the cytokine CXCL9 could become a potential therapeutic target for human CGGN.
引用
收藏
页码:394 / 400
页数:7
相关论文
共 50 条
  • [21] Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis
    Basset, Laetitia
    Chevalier, Sylvie
    Danger, Yannic
    Arshad, Muhammad Imran
    Piquet-Pellorce, Claire
    Gascan, Hugues
    Samson, Michel
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2015, 93 (12): : 1355 - 1367
  • [22] The role of CXCL9, CXCL10, and CXCL13 chemokines in patients with Sjögren's syndrome
    Hakbilen, Selda
    Tezcan, Dilek
    Onmaz, Duygu Eryavuz
    Yilmaz, Sema
    Korez, Muslu Kazim
    Unlu, Ali
    CLINICAL RHEUMATOLOGY, 2025, : 1635 - 1642
  • [23] Expression of CXCL9, -10, and -11 in the Aqueous Humor of Patients With Herpetic Endotheliitis
    Park, Jung-Won
    Li, Zhengri
    Choi, Ji-Suk
    Oh, Han-Jin
    Park, Soo-Hyun
    Yoon, Kyung-Chul
    CORNEA, 2012, 31 (11) : 1246 - 1250
  • [24] The chemokine CXCL9 expression is associated with better prognosis for colorectal carcinoma patients
    Wu, Zhenqian
    Huang, Xiuyan
    Han, Xiaodong
    Li, Zhongnan
    Zhu, Qinchao
    Yan, Jun
    Yu, Song
    Jin, Zhiming
    Wang, Zhigang
    Zheng, Qi
    Wang, Yu
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 78 : 8 - 13
  • [25] CXCL9 expression and polyomavirus BK infectivity in renal transplant patients with nephropathy
    Kariminik, A.
    Yaghobi, R.
    Dabiri, S.
    CELLULAR AND MOLECULAR BIOLOGY, 2016, 62 (01) : 104 - 108
  • [26] Protein expression in the setting of GvHD: CXCL9, ELAFIN AND REG3α
    Metafuni, E.
    Giammarco, S.
    De Ritis, D.
    Sora, F.
    Laurenti, L.
    Sica, S.
    Chiusolo, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S170 - S170
  • [27] Urinary Chemokines CXCL9 and CXCL10 Are Noninvasive Markers of Renal Allograft Rejection and BK Viral Infection
    Jackson, J. A.
    Kim, E. J.
    Begley, B.
    Cheeseman, J.
    Harden, T.
    Perez, S. D.
    Thomas, S.
    Warshaw, B.
    Kirk, A. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (10) : 2228 - 2234
  • [28] Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
    House, Imran G.
    Savas, Peter
    Lai, Junyun
    Chen, Amanda X. Y.
    Oliver, Amanda J.
    Teo, Zhi L.
    Todd, Kirsten L.
    Henderson, Melissa A.
    Giuffrida, Lauren
    Petley, Emma V.
    Sek, Kevin
    Mardiana, Sherly
    Gide, Tuba N.
    Quek, Camelia
    Scolyer, Richard A.
    Long, Georgina V.
    Wilmott, James S.
    Loi, Sherene
    Darcy, Phillip K.
    Beavis, Paul A.
    CLINICAL CANCER RESEARCH, 2020, 26 (02) : 487 - 504
  • [29] The role of CXCL9 and IFIH1 in insulin dependent diabetes mellitus
    Huchem, Zamen Issea
    Ghali, Kareem Hamed
    8TH INTERNATIONAL CONFERENCE ON APPLIED SCIENCE AND TECHNOLOGY (ICAST 2020), 2020, 2290
  • [30] Myocardial Chemokine Expression and Intensity of Myocarditis in Chagas Cardiomyopathy Are Controlled by Polymorphisms in CXCL9 and CXCL10
    Nogueira, Luciana Gabriel
    Barros Santos, Ronaldo Honorato
    Ianni, Barbara Maria
    Fiorelli, Alfredo Inacio
    Mairena, Eliane Conti
    Benvenuti, Luiz Alberto
    Frade, Amanda
    Donadi, Eduardo
    Dias, Fabricio
    Saba, Bruno
    Wang, Hui-Tzu Lin
    Fragata, Abilio
    Sampaio, Marcelo
    Hirata, Mario Hiroyuki
    Buck, Paula
    Mady, Charles
    Bocchi, Edimar Alcides
    Stolf, Noedir Antonio
    Kalil, Jorge
    Cunha-Neto, Edecio
    PLOS NEGLECTED TROPICAL DISEASES, 2012, 6 (10):